Concepedia

Author

Bethany Girard

Moderna Therapeutics (United States)ORCID

Also Known As

Bethany Girard, Bethany M Biron-Girard

65

Publications

2.2K

Citations

22

H-Index

29

Concepts

All Affiliations

Moderna Therapeutics (United States)Brigham and Women's HospitalMeridian Clinical ResearchBaylor College of MedicineDuke Medical Center
BG

About

Bethany Girard is an author at Moderna Therapeutics (United States) specializing in vaccine development, covid-19, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

355

2

Immunology

9

9

355

3

Epidemiology

3

3

56

4

Public Health

1

1

14

5

Clinical Immunology

1

1

12

Bethany Girard

×

26

Publications

2K

Citations

20

H-Index

YearCitations

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky,

New England Journal of Medicine

2022

638

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

C. Buddy Creech, Evan J. Anderson, Vladimir Berthaud,

New England Journal of Medicine

2022

170

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

Spyros Chalkias, Frank Eder, Brandon Essink,

Nature Medicine

2022

143

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud,

New England Journal of Medicine

2022

136

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

Dean Follmann, Holly Janes, Olive D. Buhule,

Annals of Internal Medicine

2022

134

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

Laurence Chu, Keith Vrbicky, David C. Montefiori,

Nature Medicine

2022

100

Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines

Spyros Chalkias, Nichole McGhee, Jordan L. Whatley,

2023

79

A Bivalent Omicron-containing Booster Vaccine Against Covid-19

Spyros Chalkias, Charles Harper, Keith Vrbicky,

2022

76

Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results

Spyros Chalkias, Jordan L. Whatley, Frank Eder,

Nature Medicine

2023

68

Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines

Spyros Chalkias, Nichole McGhee, Jordan L. Whatley,

The Journal of Infectious Diseases

2024

61

Page 1